• Oligo (dT) 25 Beads: Redefining Eukaryotic mRNA Isolation Fi

  2026-05-25

  Discover how Oligo (dT) 25 Beads harness superparamagnetic technology for unparalleled eukaryotic mRNA isolation. This deep dive reveals their molecular precision, application in complex assays, and how they enable innovation beyond conventional protocols.

• AO/PI Double Staining Kit: Practical Guide for Cell Viabilit

  2026-05-24

  The AO/PI Double Staining Kit offers a streamlined, dual-fluorescent approach for distinguishing viable, apoptotic, and necrotic cells in a single workflow. It is suited for researchers needing rapid, reliable cell viability, apoptosis, and necrosis detection across various cell types, but is not intended for applications outside nucleic acid-based viability assessment or for non-fluorescent platforms.

• Sumatriptan’s Anti-Inflammatory Potential: Systematic Review

  2026-05-23

  Ala et al. systematically reviewed the anti-inflammatory actions of sumatriptan, revealing its capacity to modulate key cytokines and inflammatory pathways beyond its established use for migraine. The findings highlight new opportunities for drug repositioning and illuminate potential mechanisms relevant for translational research.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Precision Ad

  2026-05-22

  This review synthesizes recent advances in CXCR4-targeted imaging ligands and therapies for lymphoma, highlighting their dual diagnostic and therapeutic (theranostic) potential. Key innovations include the integration of peptide-based radiotracers and small-molecule antagonists to improve disease localization, prognosis, and response prediction, supporting precision oncology strategies.

• HOBt (1-Hydroxybenzotriazole) in Peptide Synthesis: Precisio

  2026-05-22

  HOBt (1-Hydroxybenzotriazole) stands at the forefront of peptide synthesis, enabling high-fidelity amide bond formation and minimizing epimerization. Discover how APExBIO’s high-purity HOBt streamlines workflows, supports synthesis of complex therapeutics, and offers reproducible results even for challenging substrates.

• Metabolite Regulation of TET2: Protocol Innovations and Impl

  2026-05-21

  Zhang et al. provide a detailed protocol integrating biochemical assays with STD NMR spectroscopy to systematically identify and validate metabolite binding to human TET2 dioxygenase. This work enables high-resolution analysis of activators and inhibitors of TET2, advancing studies on the metabolic-epigenetic interface and its implications for disease models.

• Streptozotocin: Advanced Mechanistic Insights for Diabetes R

  2026-05-21

  Discover how Streptozotocin (STZ) enables precise modeling of β-cell apoptosis and experimental diabetes mellitus induction. This article delivers an in-depth analysis of STZ’s unique mechanisms, protocol optimization, and translational value beyond standard practices.

• Calpain Inhibitor I, ALLN: Workflow Guidance for Apoptosis &

  2026-05-20

  Calpain Inhibitor I, ALLN is a potent and selective inhibitor designed for precise inhibition of calpain and cathepsin proteases in apoptosis assays and ischemia-reperfusion injury models. It is not intended for diagnostic or clinical use, and strict protocol adherence is required to ensure reproducibility and compound stability.

• Early Pheromone Perception Drives Neurodegeneration in C. el

  2026-05-20

  Peng et al. (2023) reveal that exposure to specific pheromones during early development in C. elegans induces persistent neurodevelopmental changes that accelerate neurodegeneration in adulthood. This mechanistic insight links environmental chemical cues to long-term neuronal health, offering a potential model for exploring environmental impacts on neurodegenerative disease.

• Tamsulosin in Urological Research: Protocols and Performance

  2026-05-19

  Tamsulosin, a selective α₁A-adrenergic receptor antagonist, enables high-precision modeling of smooth muscle relaxation and ureteral stone expulsion. Leveraging robust meta-analytic evidence, this guide details optimized protocols, troubleshooting, and advanced applications that position APExBIO’s Tamsulosin (C6445) as a gold-standard tool for translational and preclinical urological workflows.

• Actinomycin D: Precision Transcriptional Control in Translat

  2026-05-19

  This article explores how Actinomycin D, a gold-standard transcriptional inhibitor, empowers translational researchers to dissect nucleolar homeostasis, DNA damage response, and apoptosis induction in cancer and vascular malformation models. By bridging mechanistic insights on DNA intercalation with strategic protocol guidance, we illuminate the competitive landscape and unique translational opportunities for ActD—culminating in a forward-looking perspective on its role in advanced molecular workflows.

• Palonosetron Hydrochloride: Advances in CINV Prevention Stra

  2026-05-18

  This review analyzes Ruhlmann & Herrstedt's evaluation of palonosetron hydrochloride for chemotherapy-induced nausea and vomiting (CINV). The study highlights palonosetron's unique pharmacological profile, focusing on its receptor binding dynamics and extended efficacy in both acute and delayed CINV phases, with implications for optimizing antiemetic regimens.

• PVC Biofilm Resistance and Hexetidine Activity in VAP Contex

  2026-05-18

  This study reveals the rapid development of biofilm and antimicrobial resistance on poly(vinyl chloride) (PVC) surfaces relevant to ventilator-associated pneumonia (VAP). It highlights Hexetidine’s superior efficacy over antibiotics against mature biofilms, informing strategies for managing device-related infections.

• RSV NS3 Modulates Host Signaling for Pathogenicity Balance

  2026-05-17

  Zhuang et al. (2025) elucidate how Rice stripe virus (RSV) NS3 protein fine-tunes pathogenicity and transmission by orchestrating host kinase signaling pathways. This mechanistic insight into phosphorylation-dependent interactions advances our understanding of plant-virus-vector co-survival strategies and offers new directions for translational research.

• CAFs Drive Chemoresistance in Prostate Cancer via ANGPTL4-IQ

  2026-05-16

  This study reveals that cancer-associated fibroblasts (CAFs) promote chemoresistance in prostate cancer by enhancing mitochondrial metabolism through the ANGPTL4-IQGAP1 axis. The findings highlight potential molecular targets to improve therapeutic strategies and underscore the importance of metabolic crosstalk in the tumor microenvironment.

11785 records 2/786 page Previous Next 12345 下5页 Last page